1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Complications
Complication Platelet Testing/PED Group (N = 511) (% [n]) PED Alone Group (N = 187) (% [n]) P Value Primary outcome: neurologic morbidity and neurologic mortality 8.8 (45) 3.2 (6) .01 Secondary outcomes Spontaneous rupture 0.6 (3) 0.5 (1) 1 Intracranial hemorrhage 2.3 (12) 0.0 (0) .04 Ischemic stroke 5.5 (28) 2.1 (4) .07 Parent artery stenosis 0.2 (1) 0.5 (1) .46 Cranial neuropathy 0.4 (2) 0.0 (0) 1 Neurologic morbidity 8.2 (42) 2.1 (4) <.01 Neurologic mortality 3.5 (18) 1.1 (2) .12 All-cause mortality 4.1 (21) 1.1 (2) .05